Update shared on30 Jul 2025
Fair value Increased 7.56%Despite a notably weaker revenue growth outlook and a higher future P/E, LivePerson's consensus price target has increased from $0.86 to $0.925, reflecting an upward adjustment in fair value expectations.
What's in the News
- LivePerson provided Q2 2025 revenue guidance of $57–$60 million, representing a 29% to 25% year-over-year decline; recurring revenue to comprise 93% of total.
- Full-year 2025 revenue guidance reaffirmed at $240–$255 million, indicating an 18%–23% year-over-year decline, with recurring revenue expected at 93% of the total.
- Received Nasdaq notice for non-compliance with the $1.00 minimum bid price requirement after shares traded below this level for 30 consecutive business days; has until October 28, 2025, to regain compliance or face potential delisting.
Valuation Changes
Summary of Valuation Changes for LivePerson
- The Consensus Analyst Price Target has risen from $0.86 to $0.925.
- The Consensus Revenue Growth forecasts for LivePerson has significantly fallen from -10.2% per annum to -12.8% per annum.
- The Future P/E for LivePerson has significantly risen from 4.77x to 5.45x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.